| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.008 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.09 |